# Analysis Review Report: miRNA_qpcr_reanalysis.ipynb & 2026-03-28-session-statistical-review-reproduction.ipynb

## A) Executive Summary

- **Section status:** Completed strict, read-only multi-agent audit for both notebooks using the required sequence and governing specs.
- **Readiness decision (gate-enforced):**
  - miRNA_qpcr_reanalysis.ipynb → **conditional**
  - 2026-03-28-session-statistical-review-reproduction.ipynb → **blocked**
- **Highest blocker per notebook:**
  - Notebook 1: **material leakage risk** in searched panel/marker paths (selection done with full-data signal before CV; Section 13–16 Cell 24, Section 14 Cell 27, robustness Cell 34).
  - Notebook 2: **high QA/provenance dependency blocker** (core adjudication depends on upstream exported artifacts; File Checks/Registry Cell 5; q09 closeout still “needs repeat analysis,” Cell 27).
- **Confidence statements:**
  - Notebook 1: **Moderate confidence** for non-searched internal discrimination; **low confidence** for panel superiority/biomarker-specific interpretation.
  - Notebook 2: **Moderate confidence** for internal adjudication direction (structure-driven interpretation), but **not final-ready** due unresolved QA/provenance and closeout dependency.

---

## B) Specialist Findings by Notebook

### Notebook 1 — miRNA_qpcr_reanalysis.ipynb

#### Spec Mapper
- **Status:** partial
- **Evidence location:** Opening/setup/file checks (Cells 1–3), directives/registries/analysis blocks (Cells 5–41)
- **Blocking level:** high
- **Notebook action:** Fill missing directive-complete items (explicit data dictionary, fuller baseline clinical block, checkpoint coverage, full fresh-kernel evidence).
- **Claim ceiling impact:** “Fully implemented spec” claims are capped.

**Key details:** D11 blocked (no explicit data dictionary), D14 blocked (baseline clinical rigor incomplete), D03 blocked (fresh-kernel proof absent in current runtime view).

#### Data QA Auditor
- **Status:** partial
- **Evidence location:** setup and data-validation blocks (Cells 2, 5, 9–11, 24)
- **Blocking level:** moderate
- **Notebook action:** enforce strict S/G/P assertions, plausibility/range gates, and source-provenance lock.
- **Claim ceiling impact:** interpretations remain conditional on input integrity checks.

#### Biostatistics Reviewer
- **Status:** completed (verdict: **conditional/revise**)
- **Evidence location:** tests/modeling/final synthesis blocks (Cells 14–17, 19–22, 23–29, 31–35, 37, 40–41)
- **Blocking level:** moderate
- **Notebook action:** explicit assumption diagnostics, multiplicity-family declarations, broader uncertainty intervals.
- **Claim ceiling impact:** predictive/statistical claims remain conditional internal evidence.

#### Modeling Leakage Auditor
- **Status:** completed
- **Evidence location:** Section 13–16 (Cell 24), Section 14 (Cell 27), Checkpoint (Cell 30), robustness (Cell 34)
- **Blocking level:** high
- **Notebook action:** move marker/panel selection fully inside training folds (nested), rerun panel-derived metrics.
- **Claim ceiling impact:** **predictive claims capped** for searched models/panels.

**Leakage classification:** **material** (gate triggers cap).

#### Interpretation Reviewer
- **Status:** completed
- **Evidence location:** predictive/confounding/robustness/final synthesis/clinical blocks (Cells 22, 24–29, 32–35, 37)
- **Blocking level:** high
- **Notebook action:** remove or reframe unsupported biological/clinical independence language.
- **Claim ceiling impact:** biological + clinical claims are **unsupported** and cannot be upgraded.

---

### Notebook 2 — 2026-03-28-session-statistical-review-reproduction.ipynb

#### Spec Mapper
- **Status:** partial
- **Evidence location:** opening/setup/registry + q01–q09 + final cells (Cells 1–28)
- **Blocking level:** high
- **Notebook action:** complete missing governing-spec artifacts (full data dictionary, full fixed-task coverage, checkpoints, final completion map/results registry/repro closeout).
- **Claim ceiling impact:** not eligible for full-governed completion claim.

#### Data QA Auditor
- **Status:** partial
- **Evidence location:** Cell 5, Cell 7, Cell 11, Cell 27
- **Blocking level:** high
- **Notebook action:** remove core dependency on upstream exports for required evidence, fix derivation mapping (permutation key mismatch), enforce strict coding/plausibility assertions, complete mandated rerun in notebook.
- **Claim ceiling impact:** only conditional reproduction, not independent QA-cleared acceptance.

**Readiness gate triggered:** unresolved **high** QA issue on required inputs ⇒ downstream acceptance blocked.

#### Biostatistics Reviewer
- **Status:** completed (verdict: **conditional/revise**)
- **Evidence location:** q01–q09 and bottom line (Cells 10–28)
- **Blocking level:** moderate
- **Notebook action:** full diagnostics for parametric components, multiplicity framing across repeated model-delta families, reproducibility-tolerance quantification.
- **Claim ceiling impact:** conditional internal adjudication only.

#### Modeling Leakage Auditor
- **Status:** completed
- **Evidence location:** nested CV helper and q03/q05/q06 blocks (Cells 9, 15, 18, 20)
- **Blocking level:** none
- **Notebook action:** none (for leakage specifically).
- **Claim ceiling impact:** none from leakage; still internal-only wording.

**Leakage classification:** **none**.

#### Interpretation Reviewer
- **Status:** completed
- **Evidence location:** q03/q05/q06/q07/q08/q09 + bottom line (Cells 14–28)
- **Blocking level:** moderate
- **Notebook action:** keep downgrade framing; do not upgrade to biomarker specificity; keep clinical claims downgraded.
- **Claim ceiling impact:** strongest ceiling remains tentative internal interpretation.

---

## C) Cross-Notebook Consistency Matrix

| Domain | Agreement | Conflict | Root-cause dependency lane |
|---|---|---|---|
| Fixed groups/tasks framing | Both largely preserve S/G/P and fixed tasks in narrative | Notebook 2 lacks full fixed-task classification implementation breadth (Task1 gaps) | Spec completeness gap (D18 + D24) |
| QA readiness | Both have QA gaps | Notebook 2 has **high** provenance/dependency blocker; Notebook 1 moderate QA | Data provenance + recompute dependency (Cell 5, q09 Cell 27) |
| Statistical rigor | Both conditional/revise | Notebook 2 stronger adjudicative framing; Notebook 1 broader but uneven diagnostics | Assumptions + multiplicity coverage differences |
| Leakage | Notebook 2 passes leakage audit | Notebook 1 has material leakage in searched panel paths | Feature-selection containment failure (Cell 24/27/34) |
| Predictive interpretation | Both must remain internal-only | Notebook 1 panel superiority claims capped harder than Notebook 2 | Leakage + specificity confounding |
| Biological/clinical claims | Both require conservative framing | Notebook 1 biological/clinical claims flagged unsupported; Notebook 2 tentative downgrade supported | Interpretation ceiling + stronger-adjustment evidence |

**Stricter ceiling applied where disagreement exists:** use Notebook 1’s stricter predictive/biological cap when synthesizing global conclusions.

---

## D) Blockers, Claim Ceilings, and Remediation Plan

### P0 (must fix before acceptance)
1. **Notebook 2 high QA/provenance blocker** (required-input dependency + unresolved closeout rerun).
2. **Notebook 1 material leakage in searched panel/marker workflows** (fold contamination risk).
3. **Notebook 1 unsupported biological and clinical independence claims** must be removed/reframed.

### P1 (next)
1. Parametric diagnostics and multiplicity-family definitions in both notebooks.
2. Full governing-spec completion artifacts (especially Notebook 2: checkpoints, completion map, results registry style closure).
3. Explicit data dictionary + plausibility gate standardization.

### P2 (strengthening)
1. Broader uncertainty reporting for all headline metrics.
2. Reproducibility tolerance tables for reproduced vs original intermediate outputs.
3. External validation roadmap with locked pipelines.

### Maximum defensible wording (current ceiling)
- **Statistical:** “Within-dataset group differences are present and useful for hypothesis generation; confirmatory inference remains conditional.”
- **Predictive:** “Internal nested-CV discrimination is strong, but external generalization and disease specificity are not established.”
- **Biological:** “Marker-associated separation is observed, but biomarker-specific disease biology is not demonstrated.”
- **Clinical:** “Clinical association signals are largely confounded/attenuated under stronger adjustment and should be treated as exploratory.”

### Go / No-Go by claim class (strictest unresolved blocker applied)
- **Statistical:** **Conditional Go**
- **Predictive:** **No-Go for searched panel superiority claims**; **Conditional Go** for non-searched internal-performance framing
- **Biological:** **No-Go**
- **Clinical:** **No-Go** (Notebook 1), **Conditional No-Go/retain downgraded** (Notebook 2)

---

## E) Final Readiness Decision

### What can be reported now
- Conservative, internal-only finding that strong discrimination exists in this dataset.
- Structure/confounding-aware interpretation that broader/global signals and covariates explain substantial separation, especially in Task2/Task3.
- Explicitly exploratory status for panel-search results (especially Notebook 1).

### What must be fixed first
1. Notebook 2 QA/provenance high blocker and q09 “needs repeat analysis” dependency.
2. Notebook 1 material leakage path for searched panel/marker selection.
3. Notebook 1 unsupported biological/clinical independence language.

### Minimum evidence needed to unblock blocked areas
- **For predictive acceptance (Notebook 1 searched paths):** fully nested fold-contained marker/panel search logs + rerun OOF metrics + updated claim text.
- **For Notebook 2 readiness:** raw-data anchored recomputation (or strict artifact version pinning with hash checks), corrected derivation mapping, and updated q09 closeout showing completed rerun.
- **For biological/clinical claims:** stronger-adjusted clinical models in primary notebook plus consistent attenuation/persistence reporting and multiplicity-controlled diagnostics.

---

## Execution checklist (updated)

- [x] Read governing specs (miRNA-qPCR-reanalysis.md, AGENTS.md) and applied fixed S/G/P + fixed tasks.
- [x] Ran **Spec Mapper** first, covering both notebooks.
- [x] Ran **Data QA Auditor** and **Biostatistics Reviewer** in parallel.
- [x] Ran **Modeling Leakage Auditor** before predictive acceptance decisions.
- [x] Ran **Interpretation Reviewer** before final conclusions.
- [x] Applied readiness gates and strictest-blocker conflict resolution.
- [x] Produced required A→E output with evidence hooks (section names + cell numbers only).
- [x] Kept review read-only (no notebook/file edits).
- [x] Marked blocked items explicitly with minimum unblock evidence.